EBITDA for Bio-Techne (TECH)
According to Bio-Techne's latest reported financial statements, the company's current EBITDA (TTM) is $227.21M USD. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
TECH
Currently viewingEBITDASwitch metric
TTM (last 4 quarters)
$227.21M
YoY change
-30.7%
5Y CAGR
-10.5%
Peak year (2023)
$457.11M
Cumulative EBITDA
$5.01B
EBITDA history chart for Bio-Techne (TECH) from 1989 to 2025
EBITDA history table for Bio-Techne (TECH) from 1989 to 2025
| Fiscal year | Period ended | Reported | EBITDA | YoY |
|---|---|---|---|---|
| 2025 | $216.88M | -30.7% | ||
| 2024 | $313.14M | -31.5% | ||
| 2023 | $457.11M | +10.5% | ||
| 2022 | $413.76M | +65.6% | ||
| 2021 | $249.87M | -34.0% | ||
| 2020 | $378.41M | +78.6% | ||
| 2019 | $211.89M | +5.6% | ||
| 2018 | $200.60M | +11.8% | ||
| 2017 | $179.36M | -6.6% | ||
| 2016 | $191.99M | -0.5% | ||
| 2015 | $192.93M | +6.8% | ||
| 2014 | $180.57M | +4.4% | ||
| 2013 | $172.98M | -1.0% | ||
| 2012 | $174.66M | +0.6% | ||
| 2011 | $173.68M | +5.5% | ||
| 2010 | $164.58M | +3.8% | ||
| 2009 | $158.55M | +4.6% | ||
| 2008 | $151.55M | +10.6% | ||
| 2007 | $137.01M | +18.7% | ||
| 2006 | $115.46M | +11.2% | ||
| 2005 | $103.87M | +17.6% | ||
| 2004 | $88.31M | +19.2% | ||
| 2003 | $74.07M | +13.1% | ||
| 2002 | $65.51M | +11.9% | ||
| 2001 | $58.54M | +12.6% | ||
| 2000 | $52.00M | +40.5% | ||
| 1999 | $37.00M | +57.4% | ||
| 1998 | $23.50M | +33.5% | ||
| 1997 | $17.60M | +24.8% | ||
| 1996 | $14.10M | +27.0% | ||
| 1995 | $11.10M | +18.1% | ||
| 1994 | $9.40M | +14.6% | ||
| 1993 | $8.20M | +60.8% | ||
| 1992 | $5.10M | +88.9% | ||
| 1991 | $2.70M | +50.0% | ||
| 1990 | $1.80M | +125.0% | ||
| 1989 | $800,000 | — |
EBITDA values are taken from Bio-Techne's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of Bio-Techne (TECH) EBITDA is $216.88M – plunged 30.7% year-over-year.
Bio-Techne EBITDA compound annual growth for the 2020–2025 (5 years) window is -10.5%, with a net decline across the window.
Bio-Techne EBITDA plunged from $457.11M in 2023 to $216.88M in 2025, a 52.6% drawdown.
The highest annual EBITDA of $457.11M was reported in 2023. The lowest in the available history was $800,000 in 1989.
Among 8 Healthcare peers, Bio-Techne (TECH) ranks 9th; the peer median for EBITDA is $24.21B.
Bio-Techne EBITDA by Year
Bio-Techne EBITDA 2025: $216.88M
Bio-Techne EBITDA in 2025 was $216.88M, plunged 30.7% below 2024.
Bio-Techne EBITDA 2024: $313.14M
Bio-Techne EBITDA in 2024 was $313.14M, plunged 31.5% below 2023.
Bio-Techne EBITDA 2023: $457.11M
Bio-Techne EBITDA in 2023 was $457.11M, grew 10.5% from 2022. This figure represents the highest annual value in the available history.
Bio-Techne EBITDA 2022: $413.76M
Bio-Techne EBITDA in 2022 was $413.76M, surged 65.6% from 2021.
Bio-Techne EBITDA 2021: $249.87M
Bio-Techne EBITDA in 2021 was $249.87M.
See more financial history for Bio-Techne (TECH).
Sector peers — EBITDA
Companies in the same sector as Bio-Techne, ranked by their latest EBITDA.
| Company | EBITDA | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $156.73B | Healthcare |
| Johnson & Johnson (JNJ) | $41.05B | Healthcare |
| Eli Lilly and Company (LLY) | $27.94B | Healthcare |
| Merck & Co., Inc. (MRK) | $25.36B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $23.06B | Healthcare |
| AstraZeneca PLC (AZN) | $19.83B | Healthcare |
| AbbVie Inc. (ABBV) | $17.63B | Healthcare |
| Amgen Inc. (AMGN) | $15.84B | Healthcare |
Frequently asked questions
What is Bio-Techne's EBITDA?
- Latest reported EBITDA for Bio-Techne (TECH) is $227.21M (period ending December 31, 2025).
How has Bio-Techne EBITDA changed year-over-year?
- Bio-Techne (TECH) EBITDA changed -30.7% year-over-year on the latest annual filing.
What is the long-term growth rate of Bio-Techne EBITDA?
- Bio-Techne (TECH) EBITDA compound annual growth rate is -10.5% over the most recent 5 years available.
When did Bio-Techne EBITDA hit its highest annual value?
- Bio-Techne EBITDA reached its highest annual value of $457.11M in 2023.
What was Bio-Techne EBITDA in 2024?
- Bio-Techne (TECH) EBITDA in 2024 was $313.14M.
What was Bio-Techne EBITDA in 2025?
- Bio-Techne (TECH) EBITDA in 2025 was $216.88M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
TECH Overview
Company profile, financial tools, and key metrics
TECH Revenue Counter
Earns $38.55 every second. See per minute, hour, and day.
TECH Earnings Counter
Earns $2.57 per second net profit. See per minute, hour, and day.
TECH Economic Scale
Exceeds Samoa's GDP. Compare with world economies.
TECH What If Invested
What if you had invested $1,000? See historical returns from any date.
TECH How It Makes Money
Discover visual breakdown of $1.22B in revenue — where it comes from and where it goes.
TECH Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
TECH Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
TECH Daily Price Character
Balanced · 45.3% historical win rate (green days). Streaks & record days.
TECH Buybacks
2.18% TTM buyback yield. Shareholder yield & SBC comparison.
TECH Stock Split History
3 splits on record. Dates, ratios, and cumulative multiple.
TECH Dividend Profile
Yield: 0.62%. Safety: 5/8. See full history.
TECH Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
TECH Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.